Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on February 8, 2025, the Compensation Committee granted ...
Vera Therapeutics stock hits 52-week low at $31.64
Vera Therapeutics Inc. (VERA) shares tumbled to a 52-week low, touching down at $31.64 amidst a challenging market environment. According to InvestingPro data, this represents a significant drop from ...
Investing7m
Vera Therapeutics stock drops amid rival drug update
Shares of Vera Therapeutics Inc. (NASDAQ: VERA) tumbled by 17% as the market responded to updates on a competing drug that could challenge the company’s position in the IgAN market. The decline was ...
Le Lézard2h
Early Glycan Screening: Key to High-Quality Biologics Development, Upcoming Webinar Hosted by Xtalks
TORONTO, Feb. 14, 2025 /PRNewswire-PRWeb/ -- Early glycan screening is a cornerstone for ensuring long-term biologic quality and accelerating decision-making in cell line development (CLD). Glycan ...
Le Lézard2h
Leveraging The Principles of Pharma 4.0 to Enhance Preventative Maintenance, Upcoming Webinar Hosted by Xtalks
The pharmaceutical industry is highly regulated and maintains strict standards of precision. Embracing automation and the advanced digital tools conceived through the principles of Pharma 4.0 aim to ...